Dear JSCO Members,
(ASCOBT23) will be held in Yokohama, Japan and online from August 3 to 5, 2023, co-hosted by Japan Society of Clinical Oncology (JSCO) and Japanese Society of Medical Oncology (JSMO).
As innovation in technology accelerate progress in cancer care and improve patient outcomes, ASCO Breakthrough brings together oncology through leaders, med-tec pioneers, novel drug developers, practicing clinicians, and research trailblazers at this can’t-miss meeting in Asia for inspiration, collaboration, and solutions.
Now the abstract submission has been started.
And, JSCO/JSMO are jointly operating the incentives, please check the details from : https://www.jsco.or.jp/news/detail.html?itemid=319&dispmid=767
We are waiting for your participation in ASCO Breakthrough.
February 16, 2023
Koji Kono, MD, PhD
Chair, International Committee
Japan Society of Clinical Oncology